載入...
ESC Working Group Cellular Biology of the Heart: Position Paper: improving the preclinical assessment of novel cardioprotective therapies
Ischaemic heart disease (IHD) remains the leading cause of death and disability worldwide. As a result, novel therapies are still needed to protect the heart from the detrimental effects of acute ischaemia–reperfusion injury, in order to improve clinical outcomes in IHD patients. In this regard, alt...
Na minha lista:
| 發表在: | Cardiovasc Res |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Oxford University Press
2014
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4242141/ https://ncbi.nlm.nih.gov/pubmed/25344369 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/cvr/cvu225 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|